348 related articles for article (PubMed ID: 23539530)
1. Mesenchymal stem cell transplantation attenuates brain injury after neonatal stroke.
van Velthoven CT; Sheldon RA; Kavelaars A; Derugin N; Vexler ZS; Willemen HL; Maas M; Heijnen CJ; Ferriero DM
Stroke; 2013 May; 44(5):1426-32. PubMed ID: 23539530
[TBL] [Abstract][Full Text] [Related]
2. BDNF gene-modified mesenchymal stem cells promote functional recovery and reduce infarct size in the rat middle cerebral artery occlusion model.
Kurozumi K; Nakamura K; Tamiya T; Kawano Y; Kobune M; Hirai S; Uchida H; Sasaki K; Ito Y; Kato K; Honmou O; Houkin K; Date I; Hamada H
Mol Ther; 2004 Feb; 9(2):189-97. PubMed ID: 14759803
[TBL] [Abstract][Full Text] [Related]
3. Elevated brain derived neurotrophic factor levels in plasma reflect in vivo functional viability of infused mesenchymal stem cells for stroke in rats.
Nakamura H; Sasaki Y; Sasaki M; Kataoka-Sasaki Y; Oka S; Nakazaki M; Namioka T; Namioka A; Onodera R; Suzuki J; Nagahama H; Mikami T; Wanibuchi M; Kocsis JD; Honmou O
J Neurosurg Sci; 2019 Feb; 63(1):42-49. PubMed ID: 28181779
[TBL] [Abstract][Full Text] [Related]
4. Comparsion between Intravenous Delivered Human Fetal Bone Marrow Mesenchymal Stromal Cells and Mononuclear Cells in the Treatment of Rat Cerebral Infarct.
Huang AH; Zhang PP; Zhang B; Ma BQ; Guan YQ; Zhou YD
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2016 Oct; 38(5):497-506. PubMed ID: 27825404
[TBL] [Abstract][Full Text] [Related]
5. Intravenously Delivered Allogeneic Mesenchymal Stem Cells Bidirectionally Regulate Inflammation and Induce Neurotrophic Effects in Distal Middle Cerebral Artery Occlusion Rats Within the First 7 Days After Stroke.
Li X; Huang M; Zhao R; Zhao C; Liu Y; Zou H; Chen L; Guan Y; Zhang YA
Cell Physiol Biochem; 2018; 46(5):1951-1970. PubMed ID: 29719282
[TBL] [Abstract][Full Text] [Related]
6. Fibroblast Growth Factor Type 1 (FGF1)-Overexpressed Adipose-Derived Mesenchaymal Stem Cells (AD-MSC
Ghazavi H; Hoseini SJ; Ebrahimzadeh-Bideskan A; Mashkani B; Mehri S; Ghorbani A; Sadri K; Mahdipour E; Ghasemi F; Forouzanfar F; Hoseini A; Pasdar AR; Sadeghnia HR; Ghayour-Mobarhan M
Stem Cell Rev Rep; 2017 Oct; 13(5):670-685. PubMed ID: 28795363
[TBL] [Abstract][Full Text] [Related]
7. Enhanced Mesenchymal Stromal Cells or Erythropoietin Provide Long-Term Functional Benefit After Neonatal Stroke.
Larpthaveesarp A; Pathipati P; Ostrin S; Rajah A; Ferriero D; Gonzalez FF
Stroke; 2021 Jan; 52(1):284-293. PubMed ID: 33349013
[TBL] [Abstract][Full Text] [Related]
8. Mesenchymal stem cells attenuate MRI-identifiable injury, protect white matter, and improve long-term functional outcomes after neonatal focal stroke in rats.
van Velthoven CT; Dzietko M; Wendland MF; Derugin N; Faustino J; Heijnen CJ; Ferriero DM; Vexler ZS
J Neurosci Res; 2017 May; 95(5):1225-1236. PubMed ID: 27781299
[TBL] [Abstract][Full Text] [Related]
9. A comparative study of different doses of bone marrow-derived mesenchymal stem cells improve post-stroke neurological outcomes via intravenous transplantation.
Chen Y; Peng D; Li J; Zhang L; Chen J; Wang L; Gao Y
Brain Res; 2023 Jan; 1798():148161. PubMed ID: 36379315
[TBL] [Abstract][Full Text] [Related]
10. Intranasal brain-derived neurotrophic factor protects brain from ischemic insult via modulating local inflammation in rats.
Jiang Y; Wei N; Lu T; Zhu J; Xu G; Liu X
Neuroscience; 2011 Jan; 172():398-405. PubMed ID: 21034794
[TBL] [Abstract][Full Text] [Related]
11. Effects of intravenous administration of allogenic bone marrow- and adipose tissue-derived mesenchymal stem cells on functional recovery and brain repair markers in experimental ischemic stroke.
Gutiérrez-Fernández M; Rodríguez-Frutos B; Ramos-Cejudo J; Teresa Vallejo-Cremades M; Fuentes B; Cerdán S; Díez-Tejedor E
Stem Cell Res Ther; 2013 Jan; 4(1):11. PubMed ID: 23356495
[TBL] [Abstract][Full Text] [Related]
12. Mesenchymal stem cells that produce neurotrophic factors reduce ischemic damage in the rat middle cerebral artery occlusion model.
Kurozumi K; Nakamura K; Tamiya T; Kawano Y; Ishii K; Kobune M; Hirai S; Uchida H; Sasaki K; Ito Y; Kato K; Honmou O; Houkin K; Date I; Hamada H
Mol Ther; 2005 Jan; 11(1):96-104. PubMed ID: 15585410
[TBL] [Abstract][Full Text] [Related]
13. Transplantation of placenta-derived mesenchymal stromal cells upon experimental stroke in rats.
Kranz A; Wagner DC; Kamprad M; Scholz M; Schmidt UR; Nitzsche F; Aberman Z; Emmrich F; Riegelsberger UM; Boltze J
Brain Res; 2010 Feb; 1315():128-36. PubMed ID: 20004649
[TBL] [Abstract][Full Text] [Related]
14. Mesenchymal stem cells with modafinil (gold nanoparticles) significantly improves neurological deficits in rats after middle cerebral artery occlusion.
Nazarian S; Abdolmaleki Z; Torfeh A; Shirazi Beheshtiha SH
Exp Brain Res; 2020 Nov; 238(11):2589-2601. PubMed ID: 32886135
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic effect of BDNF-overexpressing human neural stem cells (HB1.F3.BDNF) in a rodent model of middle cerebral artery occlusion.
Chang DJ; Lee N; Choi C; Jeon I; Oh SH; Shin DA; Hwang TS; Lee HJ; Kim SU; Moon H; Hong KS; Kang KS; Song J
Cell Transplant; 2013; 22(8):1441-52. PubMed ID: 23044072
[TBL] [Abstract][Full Text] [Related]
16. Intranasal Stem Cell Treatment as a Novel Therapy for Subarachnoid Hemorrhage.
Nijboer CH; Kooijman E; van Velthoven CT; van Tilborg E; Tiebosch IA; Eijkelkamp N; Dijkhuizen RM; Kesecioglu J; Heijnen CJ
Stem Cells Dev; 2018 Mar; 27(5):313-325. PubMed ID: 29310519
[TBL] [Abstract][Full Text] [Related]
17. Mesenchymal stem cells expressing brain-derived neurotrophic factor enhance endogenous neurogenesis in an ischemic stroke model.
Jeong CH; Kim SM; Lim JY; Ryu CH; Jun JA; Jeun SS
Biomed Res Int; 2014; 2014():129145. PubMed ID: 24672780
[TBL] [Abstract][Full Text] [Related]
18. Human umbilical cord derived mesenchymal stem cells overexpressing HO-1 attenuate neural injury and enhance functional recovery by inhibiting inflammation in stroke mice.
Yang Y; Liu Q; Deng S; Shao Q; Peng L; Ling Y; Huang Y; Zheng S; Jiang Q; Nie D; Chen J
CNS Neurosci Ther; 2024 Feb; 30(2):e14412. PubMed ID: 37592866
[TBL] [Abstract][Full Text] [Related]
19. Intravenous infusion of mesenchymal stem cells inhibits intracranial hemorrhage after recombinant tissue plasminogen activator therapy for transient middle cerebral artery occlusion in rats.
Nakazaki M; Sasaki M; Kataoka-Sasaki Y; Oka S; Namioka T; Namioka A; Onodera R; Suzuki J; Sasaki Y; Nagahama H; Mikami T; Wanibuchi M; Kocsis JD; Honmou O
J Neurosurg; 2017 Oct; 127(4):917-926. PubMed ID: 28059661
[TBL] [Abstract][Full Text] [Related]
20. Intravenous delivery of adipose tissue-derived mesenchymal stem cells improves brain repair in hyperglycemic stroke rats.
Gómez-de Frutos MC; Laso-García F; Diekhorst L; Otero-Ortega L; Fuentes B; Jolkkonen J; Detante O; Moisan A; Martínez-Arroyo A; Díez-Tejedor E; Gutiérrez-Fernández M;
Stem Cell Res Ther; 2019 Jul; 10(1):212. PubMed ID: 31315686
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
